An accomplished courtroom advocate and counselor to management teams and boards of directors, Robert helps life sciences companies of all sizes navigate business conflicts. His industry knowledge, legal experience, and education through a B.S.E. and M.S.E. in biomedical engineering enable Robert to guide companies through all manner of patent, trade secret and commercial disputes.
Before litigation begins, Robert counsels clients on litigation threats surrounding product launches, generic or biosimilar challenges, failed collaborations, contractual breaches, and trade secret misappropriation.
Robert’s courtroom experience crosses trial and appellate courts throughout the United States and the Patent Trial and Appeal Board. And, he has advised clients on cross-border litigation strategies involving multiple U.S. and foreign jurisdictions. He has litigated disputes in technologies across the life sciences industry, including small molecules, biologics, gene therapy, medical devices, and software. Such litigations include “bet the company” actions against commercial rivals, Hatch-Waxman and BPCIA actions against generic/biosimilar challengers, and disputes with investors and licensing partners, among others.
Recognition Recognition Recognition
Recognition Recognition Recognition
2021 - 2022
Patents: Litigation (Full Coverage).
2014 - 2022
Rising Star, Intellectual Property Litigation.
2019
Rising Star List: Top Five Life Sciences Lawyers under 40.
2014
Impact Case of the Year Award for work representing Pfizer in case against Teva Pharmaceutical Industries Ltd.